PT Diagnos Laboratorium Utama Tbk

IDX:DGNS.JK

230 (IDR) • At close October 30, 2024
Bedrijfsnaam PT Diagnos Laboratorium Utama Tbk
Symbool DGNS.JK
Munteenheid IDR
Prijs 246
Beurswaarde 307,500,000,000
Dividendpercentage 0%
52-weken bereik 188 - 436
Industrie Diagnostics & Research
Sector Healthcare
CEO Engineer Mesha Rizal Sini
Website https://diagnos.co.id

An error occurred while fetching data.

Over PT Diagnos Laboratorium Utama Tbk

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; anatomical pathology laboratory tests for examination of tissues and/or body fluids; and genomics laboratory tests comprising non-invasive prenatal testing,

Vergelijkbare Aandelen

PT Millennium Pharmacon International Tbk logo

PT Millennium Pharmacon International Tbk

SDPC.JK

143 IDR

PT Pyridam Farma Tbk logo

PT Pyridam Farma Tbk

PYFA.JK

288 IDR

PT Phapros, Tbk logo

PT Phapros, Tbk

PEHA.JK

390 IDR

PT Royal Prima Tbk logo

PT Royal Prima Tbk

PRIM.JK

66 IDR

PT Merck Tbk logo

PT Merck Tbk

MERK.JK

3,700 IDR

PT Itama Ranoraya Tbk logo

PT Itama Ranoraya Tbk

IRRA.JK

472 IDR

PT Sejahteraraya Anugrahjaya Tbk logo

PT Sejahteraraya Anugrahjaya Tbk

SRAJ.JK

3,280 IDR

PT Darya-Varia Laboratoria Tbk logo

PT Darya-Varia Laboratoria Tbk

DVLA.JK

1,785 IDR

PT Indofarma Tbk logo

PT Indofarma Tbk

INAF.JK

126 IDR

PT Mark Dynamics Indonesia Tbk logo

PT Mark Dynamics Indonesia Tbk

MARK.JK

1,135 IDR

Financiële Gegevens

Cijfers zijn in miljoenen (IDR)

Cijfers zijn in miljoenen (IDR)